Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.
Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision history shows the addition of v3.3.2 and the removal of v3.2.0, reflecting administrative version-control updates to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check17 days agoChange DetectedRemoved the government funding status notice from the page. This is an administrative update that does not affect trial details or history.SummaryDifference0.5%
- Check32 days agoChange DetectedNew version 31 (2025-05-12) adds a Recruitment Status update to the study record. This update affects the current status shown in the record's history.SummaryDifference0.1%
- Check61 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference10%
- Check68 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%
- Check82 days agoChange DetectedMinor version bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' element; no substantive changes to core content or pricing.SummaryDifference0.6%
Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.